Background: Time-in therapeutic range (TTR) is defined as the time a drug concentration remains within the therapeutic range. To explore the optimal management of calcineurin inhibitor (CNI), we investigated how TTR percentage (TTR%) in two different CNI protocols relates to short-term outcomes after living-donor liver transplantation (LDLT).
Methods: TTR% was estimated for two different protocols in 352 adult LDLT recipients over 90 days in this retrospective, single-center study. Short-term outcomes were compared among the TTR% groups in each protocol.
Results: Higher TTR% was associated with better acute rejection-free survival: 96.2%, 86.1%, 74.7%, and 38.9% for TTR% ≥ 60%, ≥ 50%-< 60%, ≥ 40%-< 50%, and < 40%, in the low-target protocol, respectively (p < 0.001, log-rank test); 73.7%, 74.3%, 63.6%, and 48.3%, in the high-target protocol, respectively (p = 0.003). The incidence of adverse events was similar among TTR% groups in each protocol. Multivariate analysis revealed higher TTR% was protective for rejection-free survival, and this trend was particularly pronounced in the low-target protocol.
Conclusions: High TTR%, reflecting well-controlled CNI levels, was associated with better outcomes after LDLT. The outcome of high TTR% in low-target protocol seems better, but further prospective validation is warranted.
{"title":"Association Between Time-In-Therapeutic Range of Calcineurin Inhibitor Trough Level and Short-Term Outcomes of Recipients After Adult Living-Donor Liver Transplantation.","authors":"Ryugen Takahashi, Nobuhisa Akamatsu, Yuya Saruta, Mei Nakamura, Yujiro Nishioka, Yuichiro Mihara, Akihiko Ichida, Takeshi Takamoto, Yoshikuni Kawaguchi, Kiyoshi Hasegawa","doi":"10.1002/jhbp.70046","DOIUrl":"https://doi.org/10.1002/jhbp.70046","url":null,"abstract":"<p><strong>Background: </strong>Time-in therapeutic range (TTR) is defined as the time a drug concentration remains within the therapeutic range. To explore the optimal management of calcineurin inhibitor (CNI), we investigated how TTR percentage (TTR%) in two different CNI protocols relates to short-term outcomes after living-donor liver transplantation (LDLT).</p><p><strong>Methods: </strong>TTR% was estimated for two different protocols in 352 adult LDLT recipients over 90 days in this retrospective, single-center study. Short-term outcomes were compared among the TTR% groups in each protocol.</p><p><strong>Results: </strong>Higher TTR% was associated with better acute rejection-free survival: 96.2%, 86.1%, 74.7%, and 38.9% for TTR% ≥ 60%, ≥ 50%-< 60%, ≥ 40%-< 50%, and < 40%, in the low-target protocol, respectively (p < 0.001, log-rank test); 73.7%, 74.3%, 63.6%, and 48.3%, in the high-target protocol, respectively (p = 0.003). The incidence of adverse events was similar among TTR% groups in each protocol. Multivariate analysis revealed higher TTR% was protective for rejection-free survival, and this trend was particularly pronounced in the low-target protocol.</p><p><strong>Conclusions: </strong>High TTR%, reflecting well-controlled CNI levels, was associated with better outcomes after LDLT. The outcome of high TTR% in low-target protocol seems better, but further prospective validation is warranted.</p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Addressing Five Key Concerns—Response to Letter to the Editor","authors":"Takashi Kishi, Yoshitsugu Tajima, Masaaki Hidaka","doi":"10.1002/jhbp.70039","DOIUrl":"10.1002/jhbp.70039","url":null,"abstract":"","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"33 1","pages":"e11-e12"},"PeriodicalIF":2.8,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145634445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Bo Zou, Hao Jiang, Jingsheng Ruan, Daifeng Yang, Xing Chen, Shanshan Cai, Xinglin Yi
Background: Understanding the genetic links between acute pancreatitis (AP) and its infectious comorbidities is crucial for prognosis and therapy, yet remains underexplored.
Methods: We conducted a comprehensive post-GWAS analysis using large-scale summary statistics for AP and 16 infectious diseases. To pinpoint pleiotropic genes, we integrated multi-omics data via transcriptome-wide and proteome-wide association studies, and resolved cell-type-specific effects using single-cell analysis. Extensive locus colocalization analyses were performed to validate our findings by estimating the probability of shared causal variants.
Results: This computational discovery phase prioritized 29 high-confidence pleiotropic genes, including established loci (SPINK1, CRP) and novel candidates (ERBB2, ALDH2, FLOT1). To functionally validate and contextualize these findings, we performed bulk transcriptomic analysis on peripheral blood from AP patients and employed gsMap, a spatial GWAS mapping algorithm, to integrate our genetic data with transcriptomics from a murine AP model, comparing pathological versus normal tissue. These analyses confirmed that the identified genes are dynamically regulated in a severity-dependent manner in patients and are activated within specific pathological niches in pancreatic tissue.
Conclusion: In conclusion, this study provides a genetic map linking AP and its infectious comorbidities, offering insights into potential prevention strategies and highlighting novel therapeutic targets for further investigation and validation.
{"title":"Integrative Genomics Reveals Causal Pleiotropy and Therapeutic Opportunities at the Interface of Acute Pancreatitis and Infection.","authors":"Bo Zou, Hao Jiang, Jingsheng Ruan, Daifeng Yang, Xing Chen, Shanshan Cai, Xinglin Yi","doi":"10.1002/jhbp.70041","DOIUrl":"https://doi.org/10.1002/jhbp.70041","url":null,"abstract":"<p><strong>Background: </strong>Understanding the genetic links between acute pancreatitis (AP) and its infectious comorbidities is crucial for prognosis and therapy, yet remains underexplored.</p><p><strong>Methods: </strong>We conducted a comprehensive post-GWAS analysis using large-scale summary statistics for AP and 16 infectious diseases. To pinpoint pleiotropic genes, we integrated multi-omics data via transcriptome-wide and proteome-wide association studies, and resolved cell-type-specific effects using single-cell analysis. Extensive locus colocalization analyses were performed to validate our findings by estimating the probability of shared causal variants.</p><p><strong>Results: </strong>This computational discovery phase prioritized 29 high-confidence pleiotropic genes, including established loci (SPINK1, CRP) and novel candidates (ERBB2, ALDH2, FLOT1). To functionally validate and contextualize these findings, we performed bulk transcriptomic analysis on peripheral blood from AP patients and employed gsMap, a spatial GWAS mapping algorithm, to integrate our genetic data with transcriptomics from a murine AP model, comparing pathological versus normal tissue. These analyses confirmed that the identified genes are dynamically regulated in a severity-dependent manner in patients and are activated within specific pathological niches in pancreatic tissue.</p><p><strong>Conclusion: </strong>In conclusion, this study provides a genetic map linking AP and its infectious comorbidities, offering insights into potential prevention strategies and highlighting novel therapeutic targets for further investigation and validation.</p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145634470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To investigate the trajectory of the learning curve of single-port laparoscopic choledochal cyst excision and Roux-en-Y hepaticojejunostomy (SPCH), and to assess the determinants influencing the duration of the surgical procedure.
Methods: A prospective observative cohort was established from March 15, 2020 to May 1, 2025 to analyze the learning curve of SPCH, utilizing the cumulative sum method (CUSUM). Demographic data, imaging information, surgical details, postoperative imaging findings, and other follow-up information were recorded; multiple linear regression analysis was performed to identify factors affecting surgical outcomes.
Results: A total of 70 surgeries were completed. CUSUM analysis revealed that a cumulative 29 cases of SPCH were needed to complete the learning curve. Multiple linear regression indicated that longer operative duration was significantly related to more blood loss (β: 2.690, SE: 0.6473, 95% CI: 1.393 to 3.987, p = 0.0001) and the greater diameter of the cyst (β: 12.95, SE: 3.621, 95% CI: 5.692 to 20.20, p = 0.0007).
Conclusion: For a surgeon experienced in conventional laparoscopic choledochal cyst excision, 29 cases were required to complete the learning curve for SPCH. Repeated hemostasis and the dissection of larger cysts can significantly prolong operative duration.
{"title":"Learning Curve of Single-Port Laparoscopic Choledochal Cyst Excision and Roux-En-Y Hepaticojejunostomy in Children: A Single Surgeon's Experience.","authors":"Zhe Wang, Xi-Si Guan, Xiao-Li Xie, Yun-Pu Tan, Jia-Kang Yu, Wei Zhong","doi":"10.1002/jhbp.70035","DOIUrl":"https://doi.org/10.1002/jhbp.70035","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the trajectory of the learning curve of single-port laparoscopic choledochal cyst excision and Roux-en-Y hepaticojejunostomy (SPCH), and to assess the determinants influencing the duration of the surgical procedure.</p><p><strong>Methods: </strong>A prospective observative cohort was established from March 15, 2020 to May 1, 2025 to analyze the learning curve of SPCH, utilizing the cumulative sum method (CUSUM). Demographic data, imaging information, surgical details, postoperative imaging findings, and other follow-up information were recorded; multiple linear regression analysis was performed to identify factors affecting surgical outcomes.</p><p><strong>Results: </strong>A total of 70 surgeries were completed. CUSUM analysis revealed that a cumulative 29 cases of SPCH were needed to complete the learning curve. Multiple linear regression indicated that longer operative duration was significantly related to more blood loss (β: 2.690, SE: 0.6473, 95% CI: 1.393 to 3.987, p = 0.0001) and the greater diameter of the cyst (β: 12.95, SE: 3.621, 95% CI: 5.692 to 20.20, p = 0.0007).</p><p><strong>Conclusion: </strong>For a surgeon experienced in conventional laparoscopic choledochal cyst excision, 29 cases were required to complete the learning curve for SPCH. Repeated hemostasis and the dissection of larger cysts can significantly prolong operative duration.</p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145634459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background/purpose: Accurate assessment of tumor invasion depth is essential for determining the surgical strategy for gallbladder cancer; however, preoperative assessment remains challenging. This study assessed the utility of intraoperative narrow-band imaging (NBI) of the gallbladder serosal surface for estimating tumor invasion depth.
Methods: Thirty-nine patients with suspected gallbladder cancer underwent intraoperative observation of the gallbladder serosa using NBI. The NBI findings were classified based on vascular irregularities and correlated with postoperative histopathological data.
Results: Among the 39 patients, 26 (66.7%) were diagnosed with gallbladder cancer. All patients with positive NBI (n = 14) were pathologically confirmed to have gallbladder cancer. Positive NBI was significantly associated with ≥ T2 invasion and increased microvasculature in the subserosal layer (p < 0.001), as well as with lymphatic invasion (p < 0.001). Diagnostic sensitivities for ≥ T2 invasion were 79.5% for intraoperative NBI, 69.4% for plane CT, and 63.0% for EUS.
Conclusions: Intraoperative NBI may be useful for evaluating tumor depth and lymphatic involvement in patients suspected to have gallbladder cancer, which can support intraoperative surgical decision-making.
{"title":"Intraoperative Narrow-Band Imaging Predicts Invasion Depth in Gallbladder Cancer.","authors":"Yuiko Nagasawa, Teijiro Hirashita, Yukio Iwashita, Wataru Miyoshino, Shun Nakamura, Hiroomi Takayama, Yoko Kawano, Takashi Masuda, Yuichi Endo, Masafumi Inomata","doi":"10.1002/jhbp.70038","DOIUrl":"https://doi.org/10.1002/jhbp.70038","url":null,"abstract":"<p><strong>Background/purpose: </strong>Accurate assessment of tumor invasion depth is essential for determining the surgical strategy for gallbladder cancer; however, preoperative assessment remains challenging. This study assessed the utility of intraoperative narrow-band imaging (NBI) of the gallbladder serosal surface for estimating tumor invasion depth.</p><p><strong>Methods: </strong>Thirty-nine patients with suspected gallbladder cancer underwent intraoperative observation of the gallbladder serosa using NBI. The NBI findings were classified based on vascular irregularities and correlated with postoperative histopathological data.</p><p><strong>Results: </strong>Among the 39 patients, 26 (66.7%) were diagnosed with gallbladder cancer. All patients with positive NBI (n = 14) were pathologically confirmed to have gallbladder cancer. Positive NBI was significantly associated with ≥ T2 invasion and increased microvasculature in the subserosal layer (p < 0.001), as well as with lymphatic invasion (p < 0.001). Diagnostic sensitivities for ≥ T2 invasion were 79.5% for intraoperative NBI, 69.4% for plane CT, and 63.0% for EUS.</p><p><strong>Conclusions: </strong>Intraoperative NBI may be useful for evaluating tumor depth and lymphatic involvement in patients suspected to have gallbladder cancer, which can support intraoperative surgical decision-making.</p>","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":" ","pages":""},"PeriodicalIF":2.8,"publicationDate":"2025-11-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145596664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Muhammad Khubaib Iftikhar, Qurat Ul Ain Iftikhar, Mirza Mohammad Ali Baig
{"title":"From Risk Factors to Risk Stratification: Enhancing Precision in Preventing Gastric Remnant Ischemia After Distal Pancreatectomy","authors":"Muhammad Khubaib Iftikhar, Qurat Ul Ain Iftikhar, Mirza Mohammad Ali Baig","doi":"10.1002/jhbp.70037","DOIUrl":"10.1002/jhbp.70037","url":null,"abstract":"","PeriodicalId":16056,"journal":{"name":"Journal of Hepato‐Biliary‐Pancreatic Sciences","volume":"33 1","pages":"e9-e10"},"PeriodicalIF":2.8,"publicationDate":"2025-11-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145587849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
With supporting video, Takayama and colleagues demonstrate double-balloon endoscopy-assisted peroral pancreatoscopy-guided electrohydraulic lithotripsy for pancreatic duct stones in a patient with surgically altered anatomy. After balloon dilation of a pancreaticojejunostomy stricture, stones were fragmented under direct pancreatoscopic visualization and successfully removed using a spiral basket, achieving complete ductal clearance.